Article Information
History
- July 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthias Tenbusch*,1,
- Sofie Schumacher*,2,
- Emanuel Vogel3,
- Alina Priller5,
- Jürgen Held4,
- Philipp Steininger1,
- Stephanie Beileke1,
- Pascal Irrgang1,
- Ronja Brockhoff2,
- Jon Salmanton-García2,
- Kathrin Tinnefeld3,
- Hrvoje Mijocevic3,
- Kilian Schober4,
- Christian Bogdan4,
- Sarah Yazici5,
- Percy Knolle5,6,
- Oliver A. Cornely#,2,6,
- Klaus Überla#,1 and
- Ulrike Protzer#,3,6,&
- 1Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schlossgarten 4, 91054 Erlangen, Germany
- 2University Hospital of Cologne, Faculty of Medicine, Department I of Internal Medicine, Cologne, Germany, and University of Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Kerpener Str. 62, 50931 Cologne, Germany
- 3Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Zentrum München, Trogerstr. 30, 81675 Munich, Germany
- 4Institute of Microbiology – Clinical Microbiology, Immunolgy and Hygiene, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Wasserturmstr. 3, 91054 Erlangen, Germany
- 5Institute of Molecular Immunology and Experimental Oncology, School of Medicine, University Hospital rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany
- 6German Center for Infection Research (DZIF), partner sites Munich and Cologne
- ↵&Corresponding author(s)
: Prof. Dr. Ulrike Protzer, protzer{at}tum.de; protzer{at}helmholtz-muenchen.de, Director, Institute of Virology, Technical University of Munich / Helmholtz Zentrum München Trogerstr. 30, 81675 Munich, Germany, Tel: +49-89-4140 6886
↵*,# these authors contributed equally to the work
Author contributions UP, OC, KÜ designed the study, analyzed and interpreted the data and wrote the manuscript. SS, PK, PS, JH, CB, and JS-G contributed to study planning.
MT, PS, PI, EV and HM acquired, analyzed and interpreted laboratory data.
SS, EV, AP, MT, JH, SB, JSG, RB, KT and SY acquired and analyzed demographic data. SS, AP, SY, KT, JH, KS, CB, PS, SB, RB contributed to study organization and sample acquisition.
Posted July 06, 2021.
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
2
Blogs/Media
Author Videos